You are viewing an incomplete version of our website. Please click to reload the website as full version.

CBR3 antibody (Carbonyl Reductase 3) (C-Term)

Details for Product anti-CBR3 Antibody No. ABIN951030, Supplier: Log in to see
Antigen
  • MGC81473
  • CBR3
  • SDR21C2
  • hCBR3
  • 1110001J05Rik
  • C81353
Epitope
C-Term, AA 194-224
17
17
4
3
2
2
2
2
1
1
Reactivity
Human
70
14
14
5
4
3
3
Host
Rabbit
30
25
15
Clonality
Polyclonal
Conjugate
This CBR3 antibody is un-conjugated
1
1
1
1
1
1
Application
Enzyme Immunoassay (EIA), Western Blotting (WB)
58
39
18
6
4
3
3
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen KLH conjugated synthetic peptide between 194-224 amino acids from the C-terminal region of human CBR3
Isotype Ig
Specificity This antibody reacts to CBR3.
Cross-Reactivity (Details) Species reactivity (tested):Human.
Purification Saturated Ammonium Sulfate (SAS) precipitation
Alternative Name Carbonyl Reductase 3 (CBR3 Antibody Abstract)
Background Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1.Synonyms: CBR3, NADPH-dependent carbonyl reductase 3
Molecular Weight 30850 Da
Gene ID 874
NCBI Accession NP_001227
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS, 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Background publications Guey, García-Closas, Murta-Nascimento et al.: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, 2010 (PubMed).

Hosgood, Menashe, He et al.: "PTEN identified as important risk factor of chronic obstructive pulmonary disease." in: Respiratory medicine, Vol. 103, Issue 12, pp. 1866-70, 2009 (PubMed).

Zhang, Blanco: "Identification of the promoter of human carbonyl reductase 3 (CBR3) and impact of common promoter polymorphisms on hepatic CBR3 mRNA expression." in: Pharmaceutical research, Vol. 26, Issue 9, pp. 2209-15, 2009 (PubMed).